Exploration Interim Data Summary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exploration Interim Data Summary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exploration Interim Data Summary Today - Breaking & Trending Today

4DMT Presents Additional Positive Interim Data from Intravitreal 4D-150 Phase 1/2 Prism Clinical Trial in Patients with Wet AMD at ASRS 2023

Published: July 30, 2023

4D Molecular Therapeutics, Inc. announced additional positive interim clinical data from the Phase 1 Dose Exploration stage of the 4D-150 Phase 1/2 PRISM clinical trial for patients with wet...

Source: marketscreener.com

Related Topics:

United StatesChristinen KayAmerican Society Of Retinal SpecialistsD Molecular Therapeutics IncClinical Trials At Vitreoretinal Associates In GainesvilleMolecular TherapeuticsRetinal SpecialistsAnnual MeetingRetinal GeneticsClinical TrialsVitreoretinal AssociatesExploration Interim Data SummaryFuture MilestonesMarket Ophthalmology PortfolioFirst QuarterFourth QuarterThird QuarterTherapeutic Vector EvolutionNobel Prize Winning

4DMT Presents Additional Positive Interim Data from

Published: July 29, 2023

Dose response demonstrated in favor of highest tested dose of 3E10 vg/eye, including 100% reduction in supplemental anti-VEGF injections (4 of 4 evaluable...

Source: globenewswire.com

Related Topics:

United StatesRobert KimChristinen KayJulian PeiDavid KirnKatherine SmithCorporate CommunicationsClinical Trials At Vitreoretinal Associates In GainesvilleAmerican Society Of Retinal SpecialistsExchange CommissionMolecular TherapeuticsRetinal SpecialistsAnnual MeetingRetinal GeneticsClinical TrialsVitreoretinal AssociatesChief Medical OfficerChief Executive OfficerExploration Interim Data SummaryExcludes PatientMarket Ophthalmology PortfolioScientific PresentationsTherapeutic Vector EvolutionNobel Prize WinningLooking Statements